Washington, DC/--°
Updating
Subscribe free
National News

Treasury's FinCEN flags $17.5 billion in suspected healthcare fraud, with home health and hospice at the top

A new federal financial intelligence report finds banks flagged suspicious activity at a scale that dwarfs prior estimates, and law enforcement now has a roadmap it says it plans to use.

The U.S. Treasury Department's Financial Crimes Enforcement Network released a financial trend analysis on September 9 showing that banks and other financial institutions flagged roughly $17.5 billion in suspicious activity potentially tied to healthcare fraud over a single year. The report is the largest such intelligence snapshot FinCEN has published, and it lands as the Trump administration is pressing federal agencies to move faster and harder against fraud in Medicare, Medicaid, and private insurance.

The number is big. It also needs context.

The $17.5 billion figure is a flag, not a finding. Suspicious activity reports signal potential fraud and do not establish that any specific provider broke the law. FinCEN itself cautions that reported amounts can be overly inclusive and may include attempted transactions, legal activity, and filer errors. That caveat matters. But the scale still tells investigators something: the banking system is seeing far more alarm signals tied to healthcare billing than at any point in recent memory.

FinCEN analyzed 5,702 Bank Secrecy Act reports filed by financial institutions between March 1, 2025 and February 28, 2026. Depository institutions filed approximately 89 percent of reports in the dataset and accounted for nearly 87 percent of the reported suspicious activity amounts. Potentially fraudulent funds were often received from a combination of federal and state programs, as well as private insurance companies. Medicare payments frequently originated from Medicare Administrative Contractors, while Medicaid payments originated from state-level administrators.

Home health sits at the center

Home health care businesses were identified as the suspected fraudulent provider in 20 percent of all healthcare fraud-related Bank Secrecy Act reports. That is the single largest share of any provider category in the dataset. FinCEN cited a Centers for Medicare and Medicaid Services estimate of improper payments of about 9.5 percent, or roughly $2.8 billion, in home health and hospice in 2025. Improper payments include billing errors and documentation problems, not only fraud. FinCEN also noted that CMS has described home health as vulnerable because Medicare trusts physicians and nurses to provide accurate diagnoses and necessary services and does not verify claims before paying them.

Los Angeles County appeared in 777 reports, far more than any other county, with Glendale, Los Angeles, Van Nuys, Burbank, and North Hollywood among its most frequently cited areas. That geographic concentration is not a surprise to federal investigators. In August, FinCEN convened law enforcement and financial institutions in Los Angeles for an engagement focused specifically on healthcare benefits fraud, including the exploitation of hospice care services. Participants discussed new and emerging fraud schemes targeting federal and state health insurance programs, associated financial typologies, and red flag indicators.

The people most exposed are often the least able to spot a problem: homebound older adults, people with disabilities, Medicaid enrollees who rely on in-home services, and patients whose adult children manage care from another city. FinCEN lists common schemes that can reach them, including billing for services never delivered, upcoding to bill for more expensive care than was provided, and stealing patients' health insurance identifiers, sometimes through bogus marketing offers.

What Treasury says it will do with this

Treasury Secretary Scott Bessent put the release squarely in the context of the administration's broader anti-fraud push. "By identifying and reporting this suspicious activity, financial institutions have given law enforcement critical insight into the illicit actors who deliberately exploit U.S. health care benefits programs," Bessent said. He added that "Treasury will continue working alongside our law enforcement partners to disrupt fraud wherever it occurs."

FinCEN said the financial intelligence could help law enforcement disrupt schemes targeting taxpayer-funded healthcare programs. The trend analysis is not an enforcement action in itself. It functions as an intelligence product: a map for federal prosecutors, FBI agents, and HHS investigators showing where the money is moving and what financial patterns look suspicious.

FinCEN issued the underlying advisory in close coordination with the FBI and the HHS Office of Inspector General, urging financial institutions to identify and report suspicious transactions potentially related to healthcare fraud schemes targeting Medicare, Medicaid, and other federal and state healthcare benefit programs. The advisory builds on Treasury's work to combat what it described as potentially billions of dollars in rampant healthcare and government benefits fraud.

Earlier this year, FinCEN issued Advisory FIN-2026-A001 in March in response to a 330 percent increase in suspicious healthcare-related filings. A new executive order in March directed federal agencies to strengthen anti-fraud systems across Medicare and Medicaid and created a dedicated anti-fraud task force with broad authority.

The June takedown set the stage

The September intelligence release follows the DOJ's largest-ever healthcare fraud enforcement action. On June 23, 2026, the Department of Justice and the Department of Health and Human Services announced the results of the 2026 National Health Care Fraud Takedown, charging 455 defendants in alleged schemes involving more than $6.5 billion in false claims. The numbers were significant: 455 defendants including 90 doctors and other licensed medical professionals, more than $182 million in seized assets. DOJ also emphasized tools beyond criminal charges, including CMS suspensions and revocations, HHS Office of Inspector General exclusions and civil monetary penalty actions, civil settlements, and administrative actions by the DEA targeting controlled-substance authority.

The government's Data Fusion Center, combining experts from DOJ, HHS-OIG, FBI, and other agencies, identified billing anomalies that led directly to prosecutions. A new Financial Intelligence Review Team opened and arrested one defendant in under seven months. Another scheme was detected because data showed patients were hospitalized at other facilities on the same days the defendant billed for behavioral health services.

DOJ stated that the takedown involved "cutting-edge use of data analytics to target the worst actors," and reported that CMS suspended 1,079 providers and revoked 1,403 billing privileges.

The FinCEN trend analysis released this week is, in effect, the raw intelligence version of what fed the June prosecutions. It tells the financial sector: this is what the fraud looks like when banks report it. It tells prosecutors: here is where to look next.

Scale, scope, and a caveat on the numbers

Filers identified subjects located in every U.S. state, as well as Puerto Rico, Guam, and the U.S. Virgin Islands. Of the approximately 13,000 subject addresses in the dataset, approximately 1.5 percent had a foreign address. Health care fraud is increasingly connected to domestic fraud networks and transnational criminal organizations that exploit federal health care programs.

FinCEN noted that "a small percentage of filers reported suspected health care fraud activity potentially involving large fraud rings or criminal networks, as well as some potential connections to foreign entities."

Between 2020 and 2025, FinCEN observed a 330 percent increase in Bank Secrecy Act reporting on healthcare fraud, with financial institutions filing a record of more than 3,800 initial reports in 2025 alone. FinCEN acknowledged that even this volume likely represents only a fraction of the actual fraud taking place.

The practical policy question in Washington now is what enforcement actually follows. The June takedown was a criminal action. The March advisory was a warning. The September trend analysis is intelligence shared publicly with the financial sector, and it carries a specific instruction: the advisory outlines more than 20 red flags designed to help banks and financial institutions detect suspicious healthcare transactions, expanding enforcement beyond providers alone, with financial institutions now positioned as active gatekeepers in healthcare fraud detection.

What to Watch

  • DOJ follow-on actions: The June 2026 takedown produced 455 charges. Prosecutors in districts with high suspicious-activity-report concentrations, particularly in the Los Angeles area, are the ones to watch for the next round of indictments. The 777 reports naming Los Angeles County alone make it the most likely jurisdiction for near-term criminal filings.
  • CMS provider suspensions: CMS suspended 1,079 providers alongside the June action. Treasury's new trend data gives the agency fresh targeting information. Watch for additional suspension and revocation announcements from CMS in the coming weeks, particularly in home health and hospice.
  • FinCEN whistleblower rule: A proposed rule that would pay financial awards to individuals who report Bank Secrecy Act violations closed its comment period in June. A final rule is pending. If finalized, it would add a new layer of enforcement pressure on providers and billing companies.
  • Congressional oversight: With the 2026 midterms approaching and Medicare solvency a perennial flashpoint, expect House and Senate committees to hold hearings on the scale of the fraud exposure FinCEN has now put on the public record.

Sources: U.S. Treasury / FinCEN press release | Medical Daily | AML Intelligence | FinCEN.gov (Los Angeles hospice engagement) | HHS-OIG 2026 Takedown | Wiley Law (Takedown analysis) | NachtLaw (whole-of-government crackdown) | Keller Grover (FinCEN whistleblower program)